Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis
Open Access
- 9 August 2017
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (52), 90371-90379
- https://doi.org/10.18632/oncotarget.20091
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Xia Wang1, Junyu Zhao2, Yong Zhang3, Xiujuan Xue4, Jie Yin3, Lin Liao2, Cuiping Xu4, Yinglong Hou3, Suhua Yan3 and Ju Liu1 1Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014 Shandong 2Department of Endocrinology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014 Shandong 3Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014 Shandong 4Department of Nursing, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014 Shandong Correspondence to: Ju Liu, email: ju.liu@sdu.edu.cn Keywords: von Willebrand factor, kinetics, acute myocardial infarction, meta-analysis Received: May 16, 2017 Accepted: July 26, 2017 Published: August 09, 2017 ABSTRACT Previous studies have shown a variation in plasma level of von Willebrand factor (vWF) in acute myocardial infarction (AMI) patients but with contentious results. In this study, we performed a meta-analysis to evaluate the kinetics of plasma vWF after AMI. A total of 11 qualified studies were obtained through systematical search in PubMed, Web of science, Cochrane Library database and CNKI, followed by search of reference lists, involving 519 AMI patients and 466 non-AMI controls. The standard mean difference (SMD) and 95% confidence intervals (95% CI) were calculated using random-effects model. Results indicated that the plasma vWF was significantly increased in the first several hours after onset of AMI (SMD = 1.94, 95% CI = 1.39–2.48, P < 0.001) and stayed at high level until 24 h (SMD = 1.17, 95% CI = 0.45–1.89, P = 0.001). Elevated level of vWF appeared to persist for one week and reduced to normal until the fourteenth day after AMI (SMD = 0.44, 95% CI = −0.14–1.02, P = 0.14). Subgroup analysis revealed that the high level of vWF lasted just for 1 day in patients with a symptom duration ≤ 6 h before admission. For patients with a symptom duration > 6 h, elevated vWF was found in all 7 days except day 1. Our findings determined the kinetics of plasma vWF after AMI, and might provide a new insight in monitoring AMI progression.Keywords
This publication has 52 references indexed in Scilit:
- von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older populationJournal of Thrombosis and Haemostasis, 2012
- ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial InfarctionCirculation, 2008
- Evidence that high von Willebrand factor and low ADAMTS‐13 levels independently increase the risk of a non‐fatal heart attackJournal of Thrombosis and Haemostasis, 2008
- Formation and function of Weibel-Palade bodiesJournal of Cell Science, 2008
- Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplastyJournal of Thrombosis and Haemostasis, 2007
- Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcomeEuropean Heart Journal, 2005
- ATP Augments von Willebrand Factor-dependent Shear-induced Platelet Aggregation through Ca2+-Calmodulin and Myosin Light Chain Kinase ActivationOnline Journal of Public Health Informatics, 2004
- Interaction of von Willebrand Factor Domain A1 with Platelet Glycoprotein Ibα-(1–289)Online Journal of Public Health Informatics, 2000
- Coronary Thrombosis. Effects of Blood Flow on the Mechanism of Thrombus Formation.Japanese Heart Journal, 1998
- Von Willebrand factor in patients evolving Q-wave versus non-Q-wave acute myocardial infarctionInternational Journal of Cardiology, 1996